Back to Agenda
Türkiye Townhall: Latest Developments and Opportunities Towards Greater International Regulatory Convergence
Session Chair(s)
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy, Merck & Co., Inc., United States
This Townhall will illustrate the opportunities and challenges facing a maturing regulatory authority. TITCK will address its ongoing adoption of ICH guidelines, its WHO Listed Agency procedure, and some novel regulatory legislations.
Learning Objective : • Illustrate TITCK latest developments towards greater international regulatory convergence • Discuss the challenges faced and opportunities for a maturing regulatory agency • Share lessons learnt from the WHO Listed Agency Review Procedure
Speaker(s)
Nihan Burul Bozkurt, PHD
Health Policies Director, Association of Research Based Pharmaceutical Companies (AIFD), Türkiye, Turkey
Opportunities for Türkiye – the Industry Perspective
Handan Öztunca
Head of Marketing Authorization Department , Turkish Medicines and Medical Devices Agency (TITCK), Turkey
Inci Ergönül
Head of Clinical Trials Department, Turkish Medicines and Medical Devices Agency (TITCK), Turkey
Musa Ilker Durak
Deputy President, TITCK, Turkey
Serhat Aladag
Quality Manager, TITCK , Turkey
The Role of Turkish National Control Laboratories in the Regulatory and Supervisory System: Future Activity Plan and International Memberships
Have an account?